Charles M. Baum - 16 Jun 2022 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Director
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Issuer symbol
PSTX
Transactions as of
16 Jun 2022
Transactions value $
$0
Form type
4
Filing time
16 Jun 2022, 20:59:22
Previous filing
06 Jun 2022
Next filing
28 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Award $0 +39.3K $0.00 39.3K 16 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Award $0 +57K $0.00 57K 16 Jun 2022 Common Stock 57K $2.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issuable upon the vesting of restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest in three successive equal annual installments following May 16, 2022.
F2 The stock option will vest and become exercisable in 36 equal monthly installments following May 16, 2022.